This inventor holds 1 USPTO granted patent. Top assignee: Joint Stock Company "Biocad". Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anna Viktorovna Eremeeva: Innovator in Pharmaceutical Composition
Introduction
Anna Viktorovna Eremeeva is a prominent inventor based in Saint-Petersburg, Russia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that target specific medical conditions. Her work is characterized by a commitment to advancing healthcare solutions through scientific research and innovation.
Latest Patents
Anna holds a patent for an "Aqueous Pharmaceutical Composition of an Anti-IL17A Antibody and Use Thereof." This patent represents her dedication to creating effective treatments that can improve patient outcomes in various medical scenarios. With 1 patent to her name, she continues to push the boundaries of pharmaceutical science.
Career Highlights
Throughout her career, Anna has been associated with the Joint Stock Company "Biocad," where she has played a crucial role in research and development. Her expertise in pharmaceutical compositions has positioned her as a valuable asset in the industry. Anna's work not only reflects her innovative spirit but also her commitment to improving healthcare through scientific advancements.
Collaborations
Anna has collaborated with notable colleagues, including Aleksandr Olegovich Iakovlev and Antonina Vasilevna Artemeva. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the pharmaceutical field.
Conclusion
Anna Viktorovna Eremeeva is a remarkable inventor whose contributions to pharmaceutical compositions are noteworthy. Her dedication to innovation and collaboration continues to inspire advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile